LAX.SH
ARCHEAN CHEMICAL IND LTD·Chemicals Companies·Chemicals & Petrochemicals Companies
Price
460.65
+0.87%52W Range
Market Cap
₹5,687.11 Cr
Traded: ₹9.91 Cr (0.17%) 0.0x
Free Float: ₹549.94 Cr (1.80% of FF traded)
Volume · 60D trend
2.17 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | -- | -9.0% | -- | +4.0% | Accelerating |
| Profit | -- | -- | -34.0% | -- | -39.0% | Decelerating |
| Return | -- | -- | +3.0% | +1.0% | -- | Decelerating |
| ROE | -- | +18.0% | +11.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 327 | 301 | 255 | 233 | 292 | 346 | 242 | 240 | 213 | 284 | 413 | 290 | 343 | 382 | 365 | 293 |
| Expenses | 260 | 257 | 200 | 171 | 214 | 257 | 162 | 166 | 141 | 197 | 267 | 195 | 208 | 188 | 205 | 175 |
| Operating Profit | 67 | 44 | 54 | 63 | 78 | 88 | 80 | 75 | 71 | 87 | 145 | 95 | 135 | 194 | 160 | 119 |
| Other Income | 6 | 5 | 7 | 6 | 8 | 8 | 9 | -29 | 10 | 12 | 9 | 11 | 11 | 8 | 7 | 19 |
| Interest | 5 | 10 | 4 | 6 | 5 | 0 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 19 | 35 |
| Depreciation | 23 | 23 | 24 | 24 | 23 | 21 | 20 | 19 | 19 | 18 | 18 | 18 | 18 | 17 | 17 | 17 |
| Profit Before Tax | 44 | 16 | 33 | 40 | 58 | 75 | 66 | 23 | 61 | 80 | 135 | 87 | 125 | 182 | 131 | 86 |
| Tax % | 31.0% | 23.0% | 28.0% | 27.0% | 31.0% | 28.0% | 27.0% | 31.0% | 26.0% | 28.0% | 25.0% | 24.0% | 25.0% | 25.0% | 25.0% | 26.0% |
| Net Profit | 30 | 12 | 24 | 29 | 40 | 54 | 48 | 16 | 45 | 58 | 102 | 66 | 94 | 137 | 98 | 64 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | 0 | -40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 2.5 | 1.1 | 1.9 | 2.4 | 3.3 | 4.3 | 3.9 | 1.3 | 3.6 | 4.7 | 8.2 | 5.4 | 7.6 | 11.1 | 8.0 | 6.6 |
| Sales Growth (YoY) | -- | -12.9% | 5.1% | -3.0% | 37.5% | 21.7% | -41.3% | -17.2% | -38.0% | -25.8% | 13.1% | -1.0% | -14.3% | 2.6% | -- | -- |
| Sales Growth (QoQ) | -- | 18.0% | 9.4% | -20.2% | -15.6% | 43.0% | 0.8% | 12.7% | -25.0% | -31.2% | 42.4% | -15.4% | -10.2% | 4.7% | 24.6% | -- |
| OP Growth (YoY) | -14.1% | -50.0% | -32.5% | -16.0% | 9.9% | 1.1% | -44.8% | -21.1% | -47.4% | -55.2% | -9.4% | -20.2% | -- | -- | -- | -- |
| OP Growth (QoQ) | 52.3% | -18.5% | -14.3% | -19.2% | -11.4% | 10.0% | 6.7% | 5.6% | -18.4% | -40.0% | 52.6% | -29.6% | -30.4% | 21.3% | 34.5% | -- |
| Profit Growth (YoY) | -- | -75.0% | -51.0% | -41.0% | -10.0% | -7.0% | -53.0% | -26.0% | -52.0% | -58.0% | 4.0% | 4.0% | 11.0% | 67.0% | 100.0% | -- |
| EPS Growth (YoY) | -- | -74.9% | -50.9% | 84.4% | -10.4% | -7.1% | -52.7% | -76.1% | -52.3% | -57.9% | 3.3% | -18.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -42.9% | -19.1% | -27.6% | -24.9% | 11.6% | 203.9% | -64.8% | -22.1% | -43.3% | 53.5% | -29.8% | -31.2% | 39.1% | 20.8% | -- |
| OP Margin | -- | 14.6% | 21.2% | 27.0% | 26.7% | 25.4% | 33.1% | 31.3% | 33.3% | 30.6% | 35.1% | 32.8% | 39.4% | 50.8% | 43.8% | 40.6% |
| Net Margin | -- | 4.0% | 9.4% | 12.4% | 13.7% | 15.6% | 19.8% | 6.7% | 21.1% | 20.4% | 24.7% | 22.8% | 27.4% | 35.9% | 26.9% | 21.8% |
| Material Cost % | -- | 13.1% | -0.4% | 0.1% | 8.8% | 3.6% | -6.5% | 5.7% | -8.5% | -2.8% | 11.4% | 6.5% | 8.7% | -6.5% | -1.8% | 10.0% |
| Employee Cost % | -- | 7.1% | 6.8% | 7.2% | 6.4% | 5.7% | 5.7% | 5.3% | 6.9% | 5.2% | 4.4% | 6.6% | 5.9% | 6.4% | 7.3% | 3.9% |
| P/S | 5.10 | 6.41 | 6.84 | 6.39 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 58.68 | 65.10 | 52.55 | 41.60 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 2.94 | 3.58 | 4.04 | 3.74 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Credit Rating
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve the Un-Audited ....
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 15, 2026 for Chemikas Speciality LLP
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas ....
Compliance certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 23, 2026 for Chemikas Speciality LLP
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Chemikas Speciality LLP
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Mutual Fund
Earnings call Transcript
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 31, 2026 for Chemikas Speciality LLP
Please find enclosed the Board Meeting Outcome - 30.07.2026 along with the Unaudited Financial Results for the quarter ended June 30, 2026.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 23, 2026 for Chemikas Speciality LLP
Reconciliation of share capital audit
Archean Chemical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve un-audited Standalone ....
Clarification on increase in the volume movement of Security across Exchanges
The Exchange has sought clarification from Archean Chemical Industries Ltd on July 16, 2026, with reference to Movement in Volume.<BR><BR>The reply is awaited.
General Update
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 13, 2026 for Chemikas Speciality LLP
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 04, 2026 for Chemikas Speciality LLP
Intimation of order under Section 270A of the Income Tax Act, 1961
Closure of Trading Window
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd
Voting Results of 17th Annual General Meeting (AGM) of the Company along with Scrutinizer''s Report
Re-appointment of M/s PKF Sridhar & Santhanam LLP, as the Statutory Auditor of the Company. Re-appointment of Mr. Kandheri Munuswamy Mohandass and Mr. Chittoor Ghatambu Sethuram as the ....
Proceedings of the 17th Annual General Meeting (AGM)
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on June 12, 2026 for Chemikas Speciality LLP
Intimation of Schedule of Analyst / Institutional Investor meetings
Subscription to the Right Issue of equity shares of its Wholly Owned Subsidiary, Acume Chemicals Private Limited
Annual Secretarial Compliance
Annual Secretarial Compliance
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on May 25, 2026 for Chemikas Speciality LLP
Schedule of Analyst / Institutional Investor meetings-360 ONE Capital (B&K) 16th Annual Investor Conference-Trinity India 2026
Annual Report 2025-26
Newspaper Publication of Notice for the 17TH AGM of the Company
Please find enclosed the Notice of 17th AGM to be held on Friday, June 12, 2026 @ 10.00 AM through VC/OAVM.
Please find enclosed the Business Responsibility and Sustainability Report 2025-26 forming part of Annual Report 2025-26.
Please find enclosed the Annual Report 2025-26 of Archean Chemical Industries Limited.
Earnings Call Transcript
Newspaper publication of the Audited (Standalone & Consolidate) Financial Results of the Company
Earnings Call Recording
The Board of Directors in its meeting held on May 11, 2026, inter alia, considered and approved the financial results, declaration dividend, re-appointment of statutory auditor, re-appointment ....
Intimation under Reg 30 of SEBI LODR for Re-appointment of Statutory Auditor & Independent Director
Announcement Under Regulation 30 of SEBI LODR - Re-appointment of Independent Directors & Re-Appointment of Statutory Auditors
The Board considered and recommended a final dividend of Rs. 2.50 per share for the year ended March 31, 2026 subject to the approval of the shareholders at the ensuing AGM of the Company.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Execution of Fiscal Support Agreement by SiCSem Private Limited (Subsidiary of Archean Chemical Industries Limited) with the Indian Semiconductor Mission ("ISM")
Investor Presentation
Intimation of Schedule for Earnings Call
Credit Ratings
5Concalls
16Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023May 2023
31 May 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Held by ETFs
1 ETFs hold aci · sorted by weight
Held by Mutual Funds
17 schemes hold aci · sorted by weight